Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: NOVOMEDIX LLC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2022-01-19 to 2023-10-19
Current total value of award: $355000
Description: SBIR CONCEPT AWARD TO NOVOMEDIX- NOVEL SMALL MOLECULES FOR THE TREATMENT OF RHABDOMYOSARCOMA